Category Archives: Cancer and neoplasms

FDA Grants Priority Review to Ivosidenib for IDH1+ Relapsed/Refractory MDS

Susan Pandya, MD The FDA has granted priority review to the supplemental new drug application (sNDA) seeking the approval of ivosidenib (Tibsovo) for the treatment of patients with IDH1-mutated, relapsed/refractory myelodysplastic syndrome (MDS).1 The sNDA is supported by data from a phase 1 trial (NCT02074839), which showed that evaluable patients with MDS in the efficacy […]

Artificial Intelligence Virtual Clinic Launches in Massachusetts

Piction Health Dermatology, a groundbreaking dermatology practice powered by artificial intelligence (AI), has launched in the state of Massachusetts.1 SOMKID/AdobeStock With the addition of Massachusetts cities including Boston and Cambridge, the virtual clinic now has 41 locations and also serves the states of Connecticut, Florida, and New Hampshire. Its mission is to democratize dermatologic care […]

Journal Digest: August 15

Journal of Cutaneous Pathology: Utility of Sequencing for ATP6AP1 and ATP6AP2 to Distinguish Between Atypical Granular Cell Tumor WithJunctional Component and Melanoma According to Warren et al, a granular cell tumor (GCT) is an S100+ neoplasm with atypical and malignant variants. GCTs make nests and can have junctional components similar to melanocytic neoplasms, causing a […]

Oncology Experts Weigh in on Burnout and Managing Work/Life Balance

“Certain things can make a big difference. They’re as simple as making sure that people are paid the same for what they’re doing, [giving] parents get parental leave regardless of their gender, and [having] secure vacation policies and coverage so that you can take time off to truly unplug and not just try to go […]

Updates on Imaging-Based Pancreatic Cancer Surveillance for Individuals With Increased Genetic and Familial Risk

Matthew B. Yurgelun, MD Pancreatic ductal adenocarcinoma (PDAC) is a notoriously lethal malignancy, due in large part to the fact that it is often diagnosed once unresectable and/or metastatic. When PDAC is found at potentially resectable stages, however, long-term cure is increasingly possible, particularly with improvements in neoadjuvant and adjuvant therapies.1 Although they account for […]

Endoscopic Ultrasound Needles Market Size & Share Analysis – Growth Trends & Forecasts (2023

New York, Aug. 15, 2023 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Endoscopic Ultrasound Needles Market Size & Share Analysis – Growth Trends & Forecasts (2023 – 2028)” – https://www.reportlinker.com/p06484067/?utm_source=GNW The COVID-19 pandemic impacted the market significantly, and the market faced considerable losses during the early pandemic. Long lockdown restrictions and restrictions […]

Dendritic cell vaccines in cancer treatment

Partner contentMedTech Dendritic cell treatment is a type of сancer immunotherapy that uses “lab-trained” immune cells to successfully find and destroy malignant neoplasms throughout the body. It is a prime candidate for adding to the cancer treatment armamentarium, as it significantly improves patient survival when used in combination with conventional treatments. Currently, dendritic cell therapy […]

Momelotinib Yields Symptom, Anemia Benefits in Pretreated Myelofibrosis

“These updated analyses from the pivotal phase 3 MOMENTUM study [NCT04173494] provide long­term evidence for durable symptom, spleen, and anemia benefits, a favorable safety profile, and survival through week 48 for momelotinib in symptomatic patients with anemia and myelofibrosis previously treated with a JAK inhibitor,” according to the study authors. Treatment with momelotinib produced enduring […]